Home 2017
Archives
No Hemodynamic Benefit With Levosimendan After Cardiac Sx
No decrease in 30-day mortality for patients undergoing hemodynamic support after cardiac sx
Intensive Strategy Addresses Hypoxemia After Cardiac Surgery
Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx
2011 Norepinephrine Shortage Upped Mortality in Septic Shock
Patients with septic shock in hospitals affected by drug shortage had increased rate of in-hospital death
ACC: Guidelines Differ on Statin Eligibility for African-Americans
More African-Americans at high risk of CV events eligible for statin therapy under ACC/AHA guidelines
ACC: Rivaroxaban Beats Aspirin for Lower Risk of Recurrent VTE
Low dose cuts risk in equipoise for continued anticoagulation; rate of bleeding similar to aspirin
Raised CTCs Precede Recurrence in Locally-Advanced NSCLC
Fifteen of 20 patients with recurrence had increase in circulating tumor cell counts post chemoradiation
ACC: TAVR Noninferior to Surgery for Severe Aortic Stenosis
Unique set of adverse events for each procedure among patients at intermediate surgical risk
ACC: Exercise May Improve Prognosis of Hypertrophic CM
Moderate-intensity exercise linked to increase in exercise capacity at 16 weeks versus usual activity
ACC: Antithrombotic Benefit Found Lacking in Low-Risk A-Fib
Researchers found low-risk patients fared better without any antithrombotic therapy
ACC: Meds Targeting PCSK9 Show Benefit for High-Risk Patients
Evolocumab and inclisiran inhibit proprotein convertase subtilisin-kexin type 9
